- Home
- JMM vs HBIO Comparison
JMM vs HBIO Comparison
Compare JMM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- HBIO
- Stock Information
- Founded
- JMM 1988
- HBIO 1901
- Country
- JMM United States
- HBIO United States
- Employees
- JMM N/A
- HBIO N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- JMM Finance
- HBIO Industrials
- Exchange
- JMM Nasdaq
- HBIO Nasdaq
- Market Cap
- JMM 58.2M
- HBIO 61.2M
- IPO Year
- JMM N/A
- HBIO 2000
- Fundamental
- Price
- JMM $6.03
- HBIO $0.99
- Analyst Decision
- JMM
- HBIO
- Analyst Count
- JMM 0
- HBIO 0
- Target Price
- JMM N/A
- HBIO N/A
- AVG Volume (30 Days)
- JMM 16.1K
- HBIO 284.5K
- Earning Date
- JMM 01-01-0001
- HBIO 03-06-2025
- Dividend Yield
- JMM 5.44%
- HBIO N/A
- EPS Growth
- JMM N/A
- HBIO N/A
- EPS
- JMM N/A
- HBIO N/A
- Revenue
- JMM N/A
- HBIO $97,732,000.00
- Revenue This Year
- JMM N/A
- HBIO N/A
- Revenue Next Year
- JMM N/A
- HBIO $4.32
- P/E Ratio
- JMM N/A
- HBIO N/A
- Revenue Growth
- JMM N/A
- HBIO N/A
- 52 Week Low
- JMM $5.29
- HBIO $0.94
- 52 Week High
- JMM $6.10
- HBIO $4.70
- Technical
- Relative Strength Index (RSI)
- JMM 45.97
- HBIO 16.00
- Support Level
- JMM $6.01
- HBIO $1.26
- Resistance Level
- JMM $6.13
- HBIO $1.43
- Average True Range (ATR)
- JMM 0.08
- HBIO 0.10
- MACD
- JMM -0.00
- HBIO -0.03
- Stochastic Oscillator
- JMM 10.53
- HBIO 6.05
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.